Erika Duffell

May 25, 2026
From Targets to Real World Impact: A Review of Models of Care for Chronic HBV and HCV in Europe
Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain public health threats in the WHO European region, where an estimated 29 million people live with chronic infection and viral hepatitis-related deaths now surpass those from HIV/AIDS and tuberculosis combined. Although effective prevention tools and antiviral treatments reduce the risk of complications, overall mortality has […]

Read More
May 9, 2026
Implementing Sustainable Liver Health in Europe: A Second EASL–Lancet Commission
In December 2021, the European Association for the Study of the Liver (EASL)–Lancet Commission on liver disease in Europe launched its first report, which highlighted an alarming increase in liver-related mortality in many European countries. The Commission proposed a roadmap for addressing the documented negative trends. However, quoting one of the accompanying Comment articles, “gaining consensus […]

Read More

English